Chief Market Strategist
Ross Givens is a veteran trader with over 15 years of experience and a former VP at a major Wall Street investment bank. Specializing in small-cap stocks and momentum-driven plays, Ross identifies high-probability setups before they hit the mainstream. As Lead Strategist at Traders Agency, he has guided hundreds of successful trades and developed multiple flagship publications.
The government erasing national debt through inflation is already underway. Here's how debt monetization works and which mining stocks stand to benefit mos
The SpaceX IPO is going LIVE today. What’s going to happen next – and does the massive hype mark the “top” for the market? Find out inside.
Agentic AI stocks are entering a new phase as 1.4B knowledge workers replace chatbots with autonomous agents. These 3 backdoor infrastructure plays could e
The pullback continues. But the question on people’s minds is – could the SpaceX IPO end the pullback? Ross investigates.
FDA drug rejection reversal almost never happens — but it did for Outlook Therapeutics. OTLK trades under $1 with an FDA decision due in roughly 60 days.
The tech selloff continues. Could it lead to a broader market selloff? Ross explores the situation inside.
Worried about the pullback? Then you need to read this as Ross’ provides valuable perspective on the whole thing.
SpaceX overvalued by half at $135 IPO price—fair value sits near $42. Here's why the momentum trade still makes sense despite the stretched valuation.
Last Friday delivered the worst day of 2026 for both the Nasdaq and S&P 500 — and the “good” jobs report may be a big reason why. Payrolls came in hotter than expected, rate-hike odds jumped, and the market finally snapped after a 9-week win streak. I’ll show you why this pullback may be healthy, why it doesn’t feel that way in real time, and how I’m preparing for the next wave of breakout opportunities.
How to get SpaceX IPO shares with just $2,000 — Fidelity just dropped their minimum requirement. Five brokers have access, but the window closes Wednesday.
Goldman Sachs copper target hits $13,735/ton as Wall Street scrambles to catch up. Copper at all-time highs with a massive supply shortage still in early s
China rare earth export restrictions are forcing a Pentagon supply chain overhaul by 2027. One $9 small cap may be the only Western source that fills the g
50,000+ traders get our daily brief before the market opens.
You're subscribed!
Check your inbox.
Free. No spam. Unsubscribe anytime.